Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

As the ovaries are close to the bladder, ovarian cancer can cause frequent urination, leaking, needing to pee with urgency, ...

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

Profiling cells from ovarian endometriosis revealed signaling interactions that may sustain legion growth, highlighting ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 ...